Objective: To investigate the e cacy and adverse reactions of methylprednisolone plus azithromycin in the treatment of children with refractory mycoplasma pneumoniae pneumonia (RMPP) and its e ect on fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (EOS). Study Design: Comparative study. Place and Duration of Study: Daqing Oil eld General Hospital, China, from June 2019 to January 2021. Methodology: A total of 102 children with RMPP were randomly divided into Group A (n = 51) and Group B (n = 51) by the random number table. Group A was treated with azithromycin alone, and Group B was treated with methylprednisolone plus azithromycin. The e cacy, adverse reactions, FeNO and EOS levels were compared. Results: The total e ective rate of treatment in Group B was higher than that in Group A (p=0.006). Time of cough disappearance, lung shadow disappearance, defervescence and hospitalisation in Group B was shorter than that in Group A (p=0.033, 0.008, 0.004 and <0.001, respectively). After treatment, the FeNO and EOS levels in Group B were lower than those in Group A (both p <0.001). Conclusion: The e cacy of methylprednisolone plus azithromycin intreatment of RMPP is better than azithromycin alone. The former can reduce the levels of FeNO and EOS more e ectively than the latter.